Estimating the morbidity and mortality associated with infections due to multidrug-resistant bacteria (MDRB), France, 2012

Colomb-Cotinat, M.; Lacoste, J.; Brun-Buisson, C.; Jarlier, V.; Coignard, B.; Vaux, S.

doi:10.1186/s13756-016-0154-z

Antimicrobial Resistance & Infection Control

Table 2 Proportion of mortality associated with infections due to MDRB, France 2012

From: Estimating the morbidity and mortality associated with infections due to multidrug-resistant bacteria (MDRB), France, 2012

Body sites	Associated deaths (%)	Reference	Year of publication
MRSA invasive infections	9.8	[19]	2003
MRSA urinary tract infections	0.2	[10, 19]	1998
MRSA respiratory tract infections	7.0	[10, 19]	1998
MRSA skin and soft tissue infections and surgical site infections	1.4	[10, 19]	1998
MRSA bone and joint infections	9.8	^d
GRE invasive infections	25.0	[14]	2002
GRE urinary tract infections	9.0	[14]	2002
GRE gastrointestinal tract infections	3.0	[14]	2002
GRE skin and soft tissue infections and surgical site infections	6.0	[14]	2002
3GC-R E. coli invasive infections	18.0	[20]	2010
3GC-R E. coli urinary tract infections	0.0	[21]	2006
3GC-R E. coli respiratory tract infections	12.9	[10, 20]	1998
3GC-R E. coli skin and soft tissue infections and surgical site infections	2.6	[10, 20]	1998
3GC-R K. pneumoniae invasive infections	18.0	[20]	2010
3GC-R K. pneumoniae urinary tract infections	0.4	[10, 20]	1998
3GC-R K. pneumoniae respiratory tract infections	12.9	[10, 20]	1998
3GC-R K. pneumoniae skin and soft tissue infections and surgical site infections	2.6	[10, 20]	1998
CR K. pneumoniae invasive infections	37.0	[22]	2010
CR K. pneumoniae urinary tract infections	0.8	[10, 22]	1998
CR K. pneumoniae respiratory tract infections	26.4	[10, 22]	1998
3GC-R K. pneumoniae skin and soft tissue infections and surgical site infections	5.4	[10, 22]	1998
CR P. aeruginosa invasive infections	33.0	[23]	2010
CR P. aeruginosa urinary tract infections	0.8	[10, 23]	1998
CR P. aeruginosa respiratory infections	23.6	[10, 23]	1998
CR P. aeruginosa skin and soft tissue infections and surgical site infections	4.8	[10, 23]	1998
CR Acinetobacter invasive infections	36.5	[24]	2007
CR Acinetobacter urinary tract infections	0.8	[10, 24]	1998
CR Acinetobacter respiratory infections	26.1	[10, 24]	1998
CR Acinetobacter skin and soft tissue infections and surgical site infections	5.3	[10, 24]	1998

^dno data could be found in literature, the fraction applied is therefore that estimated for invasive infections. Invasive infections: bacteria isolated from blood or cerebrospinal fluid

Back to article page

ISSN: 2047-2994

Contact us

General enquiries: journalsubmissions@springernature.com